| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/11/1999 | WO1999056755A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 11/11/1999 | WO1999056663A2 Stent with smooth ends |
| 11/11/1999 | WO1999049316A3 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 11/11/1999 | WO1999049064A3 Plant control genes |
| 11/11/1999 | WO1999048901A3 Sucrose-n-alkyl-asparaginates, production and use thereof |
| 11/11/1999 | WO1999048897A3 Synthesis of compounds and libraries of compounds |
| 11/11/1999 | WO1999047677A3 Polypeptides homologous to vegf and bmp1 |
| 11/11/1999 | WO1999047563A3 Ribonucleotide polypeptides containing metal |
| 11/11/1999 | WO1999045150A9 Mass spectrometric methods for biomolecular screening |
| 11/11/1999 | WO1999045031A9 Cd147 binding molecules as therapeutics |
| 11/11/1999 | WO1999043853A9 Methods and apparatus for determination of length polymorphisms in dna |
| 11/11/1999 | WO1999043796A9 Methods of using a pathogen-activatable map kinase to enhance disease resistance in plants |
| 11/11/1999 | WO1999043791A9 Diisopropyl fluorophosphatase and the utilization and production thereof |
| 11/11/1999 | WO1999042821A3 Treating cancer |
| 11/11/1999 | WO1999042574B1 Sequences of an ih ionic channel and the use thereof |
| 11/11/1999 | WO1999041608A3 Interaction between cyclin d1 and steroid receptor co-activators |
| 11/11/1999 | WO1999041402A3 Targeting of genetic vaccine vectors |
| 11/11/1999 | WO1999041007A3 Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
| 11/11/1999 | WO1999040214A3 Nucleic acid delivery vehicles |
| 11/11/1999 | WO1999040105A3 Array fabrication methods |
| 11/11/1999 | WO1999037804A3 EF-Tu mRNA AS A MARKER FOR VIABILITY OF BACTERIA |
| 11/11/1999 | WO1999037778A3 Compositions and methods for detecting and treating prostate cancer |
| 11/11/1999 | WO1999036542A8 Gene associated with disease resistance in plants |
| 11/11/1999 | WO1999029863A9 Human interferon-epsilon: a type i interferon |
| 11/11/1999 | WO1999028464A3 Cdnas and proteins belonging to the bhlh-pas superfamily of transcription regulators and methods of use |
| 11/11/1999 | WO1999027105A3 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 11/11/1999 | WO1999022773B1 Sequences for targeting metastatic cells |
| 11/11/1999 | WO1999022005B1 Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor |
| 11/11/1999 | DE19822115A1 Retrovirale Gentransfervektoren Retroviral gene transfer vectors |
| 11/11/1999 | DE19821114A1 Methode zur Identifizierung und Darstellung interindividueller DNA-Sequenzunterschiede Method for the identification and representation of inter-individual DNA sequence differences |
| 11/11/1999 | DE19820629A1 An extraction process for RNA and DNA from wooden, non-wooden and herbal plant materials |
| 11/11/1999 | DE19820608A1 New nucleic acid encoding isoamylase from wheat and related transgenic plants producing starch with altered properties |
| 11/11/1999 | DE19820607A1 New enzyme with starch synthase activity, useful for producing starch for foods and packaging materials |
| 11/11/1999 | DE19820131A1 New nikkomycin derivatives useful as antifungal agents, fungicides, insecticides and miticides |
| 11/11/1999 | DE19819962A1 Hochaktive alkalische Phosphatase Highly active alkaline phosphatase |
| 11/11/1999 | DE19819846A1 Multivalente Antikörper-Konstrukte Multivalent antibody constructs |
| 11/11/1999 | DE19819829A1 New nucleic acid encoding a nicotinic acetylcholine receptor from insects, used to identify potential insecticides |
| 11/11/1999 | DE19818541A1 Mikrobielle Herstellung von Substanzen aus dem aromatischen Stoffwechsel / III Microbial production of substances from aromatic metabolism / III |
| 11/11/1999 | CA2754182A1 Automated diagnostic analyzer and method |
| 11/11/1999 | CA2650642A1 Neisseria meningitidis antigens and compositions |
| 11/11/1999 | CA2340623A1 Method for identifying and representing interindividual differences of dna sequences |
| 11/11/1999 | CA2340622A1 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit |
| 11/11/1999 | CA2331139A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| 11/11/1999 | CA2330944A1 Pathogeniv tau mutations |
| 11/11/1999 | CA2330838A1 Neisseria meningitidis antigens and compositions |
| 11/11/1999 | CA2330819A1 Electrical integrated nucleic acid isolation, purification and detection |
| 11/11/1999 | CA2330790A1 Method and device for isolating nucleic acids |
| 11/11/1999 | CA2330765A1 Nucleic acids that control seed and fruit development in plants |
| 11/11/1999 | CA2330699A1 Multifunctional adhesin proteins and their display in microbial cells |
| 11/11/1999 | CA2329986A1 New method for the selection of clones of an expression library involving rearraying |
| 11/11/1999 | CA2329142A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 11/11/1999 | CA2328602A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 11/11/1999 | CA2328506A1 Modifying the expression of the fsh beta gene by homologous recombination |
| 11/11/1999 | CA2328505A1 Chimeric receptors |
| 11/11/1999 | CA2328483A1 Inhibitors of nf-kb activation |
| 11/11/1999 | CA2328476A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery |
| 11/11/1999 | CA2328459A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery |
| 11/11/1999 | CA2328132A1 Growth-associated protease inhibitor heavy chain precursor |
| 11/11/1999 | CA2328112A1 Methods for diagnosing and evaluating cancer |
| 11/11/1999 | CA2328087A1 Partially deleted adenoviral vectors |
| 11/11/1999 | CA2328059A1 Use of interleukin-18 as vaccine adjuvant |
| 11/11/1999 | CA2327584A1 Attenuated influenza viruses |
| 11/11/1999 | CA2327550A1 Melanocortin 1 receptor selective compounds |
| 11/11/1999 | CA2327543A1 Method of treating bladder and lower urinary tract syndromes |
| 11/11/1999 | CA2327539A1 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 11/11/1999 | CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 11/11/1999 | CA2327525A1 Electronic detection of nucleic acids using monolayers |
| 11/11/1999 | CA2327457A1 Secreted proteins and polynucleotides encoding them |
| 11/11/1999 | CA2327355A1 Human receptor molecules |
| 11/11/1999 | CA2327316A1 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 11/11/1999 | CA2327263A1 Human protease associated proteins |
| 11/11/1999 | CA2327262A1 Methods of raising animals for meat production |
| 11/11/1999 | CA2327259A1 Human transcriptional regulator molecules |
| 11/11/1999 | CA2326957A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same |
| 11/11/1999 | CA2326956A1 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
| 11/11/1999 | CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 11/11/1999 | CA2326403A1 Beta-glucosidase coding sequences and protein from orpinomyces pc-2 |
| 11/11/1999 | CA2326402A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 11/11/1999 | CA2326390A1 Novel method for the identification of clones conferring a desired biological property from an expression library |
| 11/11/1999 | CA2325567A1 Optimization of pest resistance genes using dna shuffling |
| 11/11/1999 | CA2324650A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate |
| 11/11/1999 | CA2295510A1 Use of a nuclease inhibitor or interleukin-10 (il-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 11/11/1999 | CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications |
| 11/11/1999 | CA2248963A1 Novel compounds |
| 11/11/1999 | CA2230991A1 Dna demethylase, therapeutic and diagnosic uses thereof |
| 11/10/1999 | EP0955382A2 Polymorphisms associated with hypertension |
| 11/10/1999 | EP0955381A2 Detection of fungal pathogens using the polymerase chain reaction |
| 11/10/1999 | EP0955379A2 Analysis of gene expression by display of 3'-end restriction fragments of cDNAs |
| 11/10/1999 | EP0955375A2 Method for producing optically active 4-Halo-3-hydroxybutyric acid ester |
| 11/10/1999 | EP0955374A2 Retroviral vectors for gene transfer |
| 11/10/1999 | EP0955373A2 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 11/10/1999 | EP0955372A2 Method for screening substance inhibiting activation of NF-kappa B |
| 11/10/1999 | EP0955371A2 Process for transforming monocotyledonous plants |
| 11/10/1999 | EP0955370A2 DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs |
| 11/10/1999 | EP0955369A2 High active alkaline phosphatase |
| 11/10/1999 | EP0955368A2 L-glutamic acid-producing bacterium and method for producing l-glutamic acid |
| 11/10/1999 | EP0955367A2 Recombinant nucleoprotein of toscana virus |
| 11/10/1999 | EP0955366A1 Antigenic protein originating in malassezia |
| 11/10/1999 | EP0955365A2 Crystallization of M-CSF |
| 11/10/1999 | EP0955364A2 Eukaryotic transposable element |